1193 related articles for article (PubMed ID: 12498638)
1. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
[TBL] [Abstract][Full Text] [Related]
2. Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure.
Sabra AN; Botros SS
J Parasitol; 2008 Apr; 94(2):537-41. PubMed ID: 18564758
[TBL] [Abstract][Full Text] [Related]
3. Use of fluorescent probes as a useful tool to identify resistant Schistosoma mansoni isolates to praziquantel.
Couto FF; Coelho PM; Araújo N; Kusel JR; Katz N; Mattos AC
Parasitology; 2010 Oct; 137(12):1791-7. PubMed ID: 20561394
[TBL] [Abstract][Full Text] [Related]
4. Biological characteristics of praziquantel-resistant and -susceptible isolates of Schistosoma mansoni.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
Ann Trop Med Parasitol; 2001 Oct; 95(7):715-23. PubMed ID: 11784425
[TBL] [Abstract][Full Text] [Related]
5. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.
Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K
APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853
[TBL] [Abstract][Full Text] [Related]
6. Validation of sensitivity to praziquantel using Schistosoma mansoni worm muscle tension and Ca2+-uptake as possible in vitro correlates to in vivo ED50 determination.
William S; Botros S
Int J Parasitol; 2004 Jul; 34(8):971-7. PubMed ID: 15217736
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility to praziquantel of male and female cercariae of praziquantel-resistant and susceptible isolates of Schistosoma mansoni.
Liang YS; Wang W; Dai JR; Li HJ; Tao YH; Zhang JF; Li W; Zhu YC; Coles GC; Doenhoff MJ
J Helminthol; 2010 Jun; 84(2):202-7. PubMed ID: 19765323
[TBL] [Abstract][Full Text] [Related]
9. Determination of ED50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates.
Cioli D; Botros SS; Wheatcroft-Francklow K; Mbaye A; Southgate V; Tchuenté LA; Pica-Mattoccia L; Troiani AR; El-Din SH; Sabra AN; Albin J; Engels D; Doenhoff MJ
Int J Parasitol; 2004 Jul; 34(8):979-87. PubMed ID: 15217737
[TBL] [Abstract][Full Text] [Related]
10. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni.
Manneck T; Haggenmüller Y; Keiser J
Parasitology; 2010 Jan; 137(1):85-98. PubMed ID: 19814844
[TBL] [Abstract][Full Text] [Related]
11. Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment.
Botros SS; Hammam O; Mahmoud M; Bergquist R
APMIS; 2010 Sep; 118(9):692-702. PubMed ID: 20718722
[TBL] [Abstract][Full Text] [Related]
12. Resistance to praziquantel, effect of drug pressure and stability test.
Ismail MM; Farghaly AM; Dyab AK; Afify HA; el-Shafei MA
J Egypt Soc Parasitol; 2002 Aug; 32(2):589-600. PubMed ID: 12214936
[TBL] [Abstract][Full Text] [Related]
13. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
[TBL] [Abstract][Full Text] [Related]
14. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
[TBL] [Abstract][Full Text] [Related]
15. Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt.
Botros S; Sayed H; Amer N; El-Ghannam M; Bennett JL; Day TA
Int J Parasitol; 2005 Jun; 35(7):787-91. PubMed ID: 15925597
[TBL] [Abstract][Full Text] [Related]
16. [Studies on resistance of Schistosoma to praziquantel XIV experimental comparison of susceptibility to praziquantel between PZQ-resistant isolates and PZQ-susceptible isolates of Schistosoma japonicum in stages of adult worms, miracidia and cercariae].
Li HJ; Liang YS; Dai JR; Wang W; Qu GL; Li YZ; Xing YT; Tao YH; Qian K; Jia Y; Yang ZK; Wei JY
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec; 23(6):611-9. PubMed ID: 22379813
[TBL] [Abstract][Full Text] [Related]
17. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and bioavailability of different praziquantel brands.
Botros S; El-Lakkany N; Seif el-Din SH; Sabra AN; Ibrahim M
Exp Parasitol; 2011 Feb; 127(2):515-21. PubMed ID: 21044626
[TBL] [Abstract][Full Text] [Related]
19. Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice.
Giboda M; Smith JM
J Trop Med Hyg; 1994 Apr; 97(2):98-102. PubMed ID: 8170010
[TBL] [Abstract][Full Text] [Related]
20. Drug-metabolizing enzymes and praziquantel bioavailability in mice harboring Schistosoma mansoni isolates of different drug susceptibilities.
Botros SS; El-Din SH; El-Lakkany NM; Sabra AN; Ebeid FA
J Parasitol; 2006 Dec; 92(6):1344-9. PubMed ID: 17304818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
